News

Moderna and Pfizer-BioNTech ask FDA to authorize omicron boosters for children

By Abigail Adcox
Published September 26, 2022 3:52pm ET
Add Washington Examiner on Google
Moderna and Pfizer-BioNTech ask FDA to authorize omicron boosters for children
Vaccine manufacturers Pfizer-BioNTech and Moderna have asked the U.S. Food and Drug Administration to authorize their omicron-specific COVID-19 booster candidates for school-aged children. Pfizer-BioNTech submitted an application for emergency use authorization for its updated booster targeting the omicron variant for children aged 5-11 years, while Moderna requested that the FDA expand the authorization to children […]

Vaccine manufacturers Pfizer-BioNTech and Moderna have asked the U.S. Food and Drug Administration to authorize their omicron-specific COVID-19 booster candidates for school-aged children.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Children COVID-19 FDA Vaccines